Lifecore Biomedical unit amends Alcon manufacturing agreement, extends term to Dec. 31, 2034

LIFECORE BIOMEDICAL, INC. DE

Lifecore Biomedical, LLC signed Amendment No. 3 with Alcon Research, LLC on Sept. 24, 2026, effective Nov. 1, 2026.
The amendment extends the Contract Manufacturing Agreement's Initial Term from Dec. 31, 2031 to Dec. 31, 2034, with automatic 24-month renewals.
It sets Alcon's minimum purchase obligations through 2034 and amends Lifecore's supply obligations under an exhibit.
From Nov. 1, 2026, Lifecore cannot enter new agreements for products directly competing with certain Alcon products, subject to pre-existing agreement carve-outs.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.